BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Clinical Outcome
9 results:

  • 1. Prognostic efficacy of the RTN1 gene in patients with diffuse large B-cell lymphoma.
    Zamani-Ahmadmahmudi M; Nassiri SM; Asadabadi A
    Sci Rep; 2021 Oct; 11(1):21098. PubMed ID: 34702929
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
    Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
    Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
    Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
    Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
    Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
    Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population.
    Hou X; Wang S; Zhou Y; Xu Z; Zou Y; Zhu X; Han M; Pang T; Han ZC
    Int J Hematol; 2005 Oct; 82(3):206-9. PubMed ID: 16207592
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
    Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
    Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
    Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas.
    Chang CC; Liu YC; Cleveland RP; Perkins SL
    Am J Clin Pathol; 2000 Apr; 113(4):512-8. PubMed ID: 10761452
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
    Majlis A; Pugh WC; Rodriguez MA; Benedict WF; Cabanillas F
    J Clin Oncol; 1997 Apr; 15(4):1664-71. PubMed ID: 9193367
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.